Showing results (171-180 of 178) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 178 results.
RMD Open|April 5, 2024
Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR studyVioletta Dubovyk, Georgios K Vasileiadis, Tahzeeb Fatima, et al.
The Lancet. Rheumatology|August 16, 2021
Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studiesLaura Boekel, Maurice Steenhuis, Femke Hooijberg, et al.
Annals of the Rheumatic Diseases|February 3, 2022
EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndromeGeorge C Drosos, Daisy Vedder, Eline Houben, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 28, 2016
Brief Report: The Role of Rare Protein-Coding Variants in Anti-Tumor Necrosis Factor Treatment Response in Rheumatoid ArthritisJing Cui, Dorothee Diogo, Eli A Stahl, et al.
Rheumatology (Oxford, England)|July 23, 2024
Sex differences in patient-reported outcome measures and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitorsPasoon Hellamand, Marleen G H van de Sande, Michael T Nurmohamed, et al.
Annals of the Rheumatic Diseases|July 9, 2023
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trialMikkel Østergaard, Ronald F van Vollenhoven, Anna Rudin, et al.
Annals of the Rheumatic Diseases|August 11, 2022
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an updateDaniel Aletaha, Andreas Kerschbaumer, Kastriot Kastrati, et al.
Plos One|April 8, 2015
TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traitsDorothée Diogo, Lisa Bastarache, Katherine P Liao, et al.
Pageof 18